• World Neurosurg · Mar 2017

    Risk factors for chronic subdural hematoma recurrence identified using quantitative computer-tomography analysis of hematoma volume and density.

    • Pantelis Stavrinou, Sotirios Katsigiannis, Jong Hun Lee, Christina Hamisch, Boris Krischek, Anastasios Mpotsaris, Marco Timmer, and Roland Goldbrunner.
    • Department of Neurosurgery, University Hospital of Cologne, Cologne, Germany. Electronic address: pantelis.stavrinou@uk-koeln.de.
    • World Neurosurg. 2017 Mar 1; 99: 465-470.

    ObjectiveChronic subdural hematoma (CSDH), a common condition in elderly patients, presents a therapeutic challenge with recurrence rates of 33%. We aimed to identify specific prognostic factors for recurrence using quantitative analysis of hematoma volume and density.MethodsWe retrospectively reviewed radiographic and clinical data of 227 CSDHs in 195 consecutive patients who underwent evacuation of the hematoma through a single burr hole, 2 burr holes, or a mini-craniotomy. To examine the relationship between hematoma recurrence and various clinical, radiologic, and surgical factors, we used quantitative image-based analysis to measure the hematoma and trapped air volumes and the hematoma densities.ResultsRecurrence of CSDH occurred in 35 patients (17.9%). Multivariate logistic regression analysis revealed that the percentage of hematoma drained and postoperative CSDH density were independent risk factors for recurrence. All 3 evacuation methods were equally effective in draining the hematoma (71.7% vs. 73.7% vs. 71.9%) without observable differences in postoperative air volume captured in the subdural space.ConclusionsQuantitative image analysis provided evidence that percentage of hematoma drained and postoperative CSDH density are independent prognostic factors for subdural hematoma recurrence.Copyright © 2016 Elsevier Inc. All rights reserved.

      Pubmed     Full text   Copy Citation  

      Add institutional full text...

    Notes

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.